Mutated tissue plasminogen activators and uses thereof
US9732334B2 · kind B2 · utility
0Cited by
1References
4Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Dec 17, 2015 |
| Grant date | Aug 15, 2017 |
| Priority date | — |
| Expiry date | Dec 17, 2035 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Y304/21068
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to mutated tissue plasminogen activators, and their use for treating thrombotic diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.